United Therapeutics Corporation (UTHR)
United Therapeutics Corporation PE 10: 49.02
View UTHR PE 10 with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
UTHR PE 10 Rankings
| Overall | 13th percentile | 1661 of 1919 |
| Sector | 24th percentile | 101 of 134 in Healthcare |
| Industry | 50th percentile | 4 of 8 in Drug Manufacturers - Other |
UTHR PE 10 Range, Past 5 Years
| Minimum | 49.02 | Jun 1 2012 |
| Maximum | 513.79 | Jun 2010 |
| Average | 178.77 |
About PE 10
PE 10 is the current stock price divided by the average of the last 10 years' earnings per share.
Metrics of this nature were originally popularized by Benjamin Graham, often called the father of value investing. He used used this measurement because it is less sensitive to short term economic fluctuations or accounting distortions which can affect a single year's earnings and PE ratio.
Hence, for stable businesses with long histories, PE 10 gives a better picture of price relative to historical earning power than a standard 1 year PE ratio.
Learn More
You may also be interested in these UTHR related companies
UTHR News
$UTHR Mentioned more than normal on StockTwits - Currently at 9 x average daily social activity
about 30 days ago by TradeIdeasQuant
about 30 days ago by TradeIdeasQuant
I have already accepted my losses for the day...still in half $WFM and half $UTHR. DO NOT FIGHT TO GET BACK YOUR LOSSES EVER. ACCEPT
about 30 days ago by hedgefundhell
about 30 days ago by hedgefundhell
$UTHR Ready to sprint higher and fill the gap from 8/23 $CALL http://chart.ly/je9flbf
about 33 days ago by biostock
about 33 days ago by biostock
United Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript
Apr 26, 7:40PM Seeking Alpha
Apr 26, 7:40PM Seeking Alpha
United Therapeutics Corporation Reports First Quarter 2012 Financial Results
Apr 26, 6:00AM PR Newswire
Apr 26, 6:00AM PR Newswire
Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest ROE
Apr 24, 3:44AM Benzinga
Apr 24, 3:44AM Benzinga
$UTHR downward trend looks exhausted, time to pounce http://stks.co/3MSK
about 47 days ago by TrendExhaustion
about 47 days ago by TrendExhaustion
Leerink Swann Downgrades United Therapeutics Corp. (UTHR) to Market Perform; Generic Risk
Apr 12, 7:43AM Street Insider
Apr 12, 7:43AM Street Insider
Stocks moving in and out of #MagicFormulaInvesting this week include $ORCL, $UTHR, $TRW and others http://stks.co/3AT2
about 62 days ago by MagicDiligence
about 62 days ago by MagicDiligence
$UTHR files a patent infringement lawsuit against $NVS unit over patents related to a pulmonary hypertension drug.
about 79 days ago by MilionCapital
about 79 days ago by MilionCapital
United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents
Mar 15, 7:02AM Benzinga
Mar 15, 7:02AM Benzinga
New #MagicFormulaInvesting stock United Therapeutics $UTHR. Small pharma firm. Good rev growth, solid bal sheet. One to look at closer.
about 86 days ago by MagicDiligence
about 86 days ago by MagicDiligence
United Therapeutics (UTHR) Reports FDA Accepts NDA for Oral Treprostinil
Feb 21, 7:13AM Street Insider
Feb 21, 7:13AM Street Insider
Brean Murray Carret & Co. Maintains United Therapeutics at Buy, Raises PT from $55 to $57
Feb 14, 11:39AM Benzinga
Feb 14, 11:39AM Benzinga
United Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 14, 11:38AM Seeking Alpha
Feb 14, 11:38AM Seeking Alpha
Collins Stewart: United Therapeutics Reiterates FY12/FY13 Revenue Guidance, Despite 4Q11 Miss
Feb 14, 8:57AM Benzinga
Feb 14, 8:57AM Benzinga
United Therapeutics Corp (UTHR) Reports Q4 EPS of $0.79, Reaffirms FY12, FY13 Guidance
Feb 14, 7:02AM Street Insider
Feb 14, 7:02AM Street Insider
United Therapeutics Corporation Reports 2011 Fourth Quarter and Annual Financial Results
Feb 14, 7:00AM PR Newswire
Feb 14, 7:00AM PR Newswire
$UTHR Insider Sale: $3.6M of stock sold by Paul Mahon (Evp & General Counsel) on February 2, 2012 http://stks.co/2IHV
about 115 days ago by MarketBrief
about 115 days ago by MarketBrief
United Therapeutics (UTHR) Lower As Analyst Highlights Sandoz Generic Remodulin Filing
Feb 07, 10:38AM Street Insider
Feb 07, 10:38AM Street Insider
$UTHR Insider Sale: $3.6M of stock sold by Paul Mahon (Evp & General Counsel) on February 2, 2012 http://stks.co/2GtL
about 116 days ago by MarketBrief
about 116 days ago by MarketBrief
$UTHR http://stks.co/2BCw UTHR is knocking at the door. Long on a good volume break over 50 bucks.
about 122 days ago by gig777
about 122 days ago by gig777
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| UTHR | 43.01 | -1.23 | -2.78% | 2.373B |
| UTG | 25.75 | -0.05 | -0.19% | |
| UTEK | 29.07 | -1.25 | -4.12% | 791.66M |
| UTA | 3.96 | +0.00 | +0.00% | 78.80M |
| USU | 0.7299 | +0.01 | +1.07% | 88.16M |
| USTR | 25.01 | -0.24 | -0.95% | 1.069B |
| USHS | 8.07 | -0.50 | -5.83% | 62.13M |
| USG | 13.96 | -1.46 | -9.47% | 1.624B |
| USEG | 2.22 | -0.03 | -1.33% | 61.76M |
| USD | 31.35 | -2.27 | -6.75% |